Abstract Genetic variation at 8q24 is associated with prostate, bladder, breast, colorectal, thyroid, lung, ovarian, UADT, liver and stomach cancers. However, a role for variation at 8q24 in familial clustering of upper gastrointestinal cancers has not been studied. In order to explore potential inherited susceptibility, we analyzed epidemiologic data from a population-based case-control study of upper gastrointestinal cancers from Taixing, China. The study population includes 204 liver, 206 stomach, and 218 esophageal cancer cases and 415 controls. Associations between 8q24 rs1447295, rs16901979, rs6983267 and these cancers were stratified by family history of cancer.
Introduction
Family history of cancer has been associated with several cancers, including cancers of the liver, stomach, and esophagus [1] [2] [3] [4] [5] [6] [7] . Shared environmental risk factors, such as hepatitis B and C, and Helicobacter pylori (H. pylori) infection, have been associated with liver and stomach cancers, respectively, and might have a role in familial clustering of these cancers. Familial clustering of upper gastrointestinal (GI) cancers might also be attributable to inherited genetic factors. Prospective cohort studies of twins have suggested that one-third of most cancers are attributable to inherited genetic factors [8, 9] . Genetic studies of familial cancers often focus on highly penetrant genetic mutations; however, low penetrance genetic factors have been associated with susceptibility to liver, stomach, and esophageal cancers [10] [11] [12] [13] . A few of the low penetrance genetic factors that are of great interest to cancer epidemiology are at 8q24.
Genome-wide association studies (GWAS) and casecontrol studies have associated variation at 8q24 with prostate, bladder, breast, colorectal, thyroid, lung, ovarian, UADT, liver and stomach cancers [9, 12, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Colorectal cancer cases with a family history of cancer have been observed as having a greater number of 8q24 risk alleles, in comparison to those colorectal cancer cases without a family history of colorectal cancer [25] . Additionally, in a family history-stratified analysis of cancer in a Polish population, 8q24 single nucleotide polymorphism (SNPs) were associated with prostate, laryngeal, lung, and kidney cancers among those with a family history of cancer, with noteworthy heterogeneity in family historystratified associations for laryngeal and lung cancers [26] . In this study, we stratified the association of three 8q24 SNPs (rs1447295, rs16901979, rs6983267) and liver, stomach, and esophageal cancers in a Chinese population by family history of cancer. To our knowledge, this is the first study of 8q24 SNPs, family history of cancer, and these three upper GI cancers in a Chinese population.
Methods

Study design and participants
Epidemiologic data and biological specimens were collected in a population-based case-control study in Taixing City, Jiangsu Province, China. Study protocols were approved by the Institutional Review Board at the University of California, Los Angeles and all participants provided written informed consent. The study design and population have been described in detail elsewhere [13, 27, 28] . Briefly, eligible cases and controls were residents of Taixing City for at least 10 years and were at least 20 years of age at the time of recruitment. Newly diagnosed cases of stomach, liver, and esophageal cancers were identified between June 1, 2000 and December 30, 2000 using the Taixing Population-based Tumor Registry from the Taixing Center for Disease Prevention and Control. Population-based controls were randomly selected from a list of Taixing City residents and frequency-matched to all upper GI cases on sex, age (5-year categories), and residential village or block. The participation rates were 65 % for stomach (n = 206), 57 % for liver (n = 204), 67 % (n = 218) for esophageal cancer cases, and 89 % (n = 415) for controls.
Epidemiologic data and biological specimen collection Epidemiologic data were collected by a standard questionnaire during 40-60 min interviews with a trained interviewer. Questionnaires were standardized with questions on common exposures, in addition to specific questions for each cancer site. The collected data include demographics, personal habits, cigarette smoking, passive smoke exposure, alcohol consumption, tea consumption, occupational history, family history of cancer in consanguineal relatives and non-consanguineal spouses, frequency of diet and food intake, and medical history. DNA was isolated from peripheral blood samples collected from 395 interviewed controls and from 196 stomach, 194 liver, and 205 esophageal cancer cases interviewed. Measurement of exposure to hepatitis B and Helicobacter pylori (H. pylori) has been described previously [13, 28] . Plasma aflatoxin B1 (AFB1)-albumin adduct levels were determined using a competitive enzyme-linked immunosorbent assay, as described previously [29] . Biological specimens have been stored at -70°C in the Molecular Epidemiology Laboratories of Fudan University School of Public Health and the University of California, Los Angeles School of Public Health.
SNP selection and genotyping
Taixing study biospecimens were previously genotyped for three 8q24 SNPs (rs1447295, rs16901979, rs6983267) and main associations reported [30] . Genotypic data for all three 8q24 SNPs are included in this study given the location of the SNPs in unique regions of 8q24, published associations in GWAS and case-control studies of colorectal and prostate cancers, and linkage disequilibrium (LD) below the threshold of r 2 = 0.80 [14, 15, 18, [31] [32] [33] [34] . SNP genotyping was performed on a TaqMan platform with an ABI 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA). SNP-specific primers and probes were custom-designed for the ABI TaqMan system. Approximately 5 % of samples were randomly selected and duplicated for quality control. The concordance rate between duplicates was[99 %. The automatic call rates were[96 % for all three SNPs. Laboratory technicians were blinded to the case/control status of all samples and to the inclusion of duplicate samples for quality control.
Statistical analysis
All data analyses were performed using SASv9.2 software (SAS Institute Inc., Cary, NC, USA). Linkage disequilibrium between 8q24 SNPs was examined using the Proc Allele command in SAS for pairwise comparison of all three 8q24 SNP alleles in controls. Family history of any cancer (yes or no) and family history of index cancer (yes or no) were determined by self-reported history of cancer in at least one consanguineal relative (mother, father, sister, brother, daughter, son, grandfather, grandmother, maternal/ paternal uncle, maternal/paternal aunt). Unconditional logistic regression was used to estimate crude and adjusted odds ratios (OR adj ) and their 95 % confidence intervals (CI). Covariates adjusted for include age (continuous), sex (male = 0 or female = 1), education (illiterate = 0, primary school = 1, middle school = 2, senior high school/ bachelor/higher degree = 3), smoking status (never = 0 or ever = 1), number of smoking pack-years (continuous), alcohol drinking frequency (never = 0, occasionally = 1, often = 2, everyday = 3), body-mass-index [BMI (kg/m 2 ), continuous], AFB1-albumin adduct levels (liver only, quintiles), hepatitis B serum antigen (liver only, positive = 1 or negative = 0), and H. pylori infection (stomach only, positive = 1 or negative = 0). The Taixing study population is 100 % Han Chinese, therefore, ethnicity was not included as a covariate.
Tests for Hardy-Weinberg Equilibrium and differences in minor allele frequencies were previously evaluated for all three SNPs using the v 2 test [30] . We used the TT genotype as the referent for rs6983267 and the CC genotype as the referent for rs1447295 and rs16901979, so that odds ratios were modeled for the genotype homozygous for the cancer risk alleles [35] [36] [37] . Odds ratios for the stratified analysis were estimated using unconditional logistic regression, with adjustment for previously described covariates.
Cancer risk estimation can be improved by examining multiple loci simultaneously [38] [39] [40] . Therefore, in this study, we use a simple count approach to genetic risk scoring to examine the three 8q24 SNPs collectively for potential improvement in the risk estimated with each individual SNP. Under the simple count approach, we calculated a SNP-set score by assigning a value of ''0'' to the major homozygous genotype of each SNP and ''1'' to the heterozygous and minor homozygous genotype of each SNP (dominant model). In order to reduce the bias caused by missing data, we did not include any participants who had one or more missing genotypes for the 8q24 SNPs. Values were summed across all three SNPs in order to determine a SNP-set score for each participant. The dominant model was chosen based on our previously published analysis of the main association of each SNP with each cancer site [30] .
To test for departures from multiplicativity, we compared the full unconditional logistic regression model with the product term [family history 9 SNP (dichotomized under the dominant model)] to the full model without the product term. The antilog of the coefficient estimated for the product term was interpreted as the ratio of odds ratios (ROR), with a ROR = 1 indicating a departure from multiplicativity and from the null hypothesis. The RORs and their 95 % CIs were estimated using unconditional logistic regression, with adjustment for previously described covariates.
Results
Select characteristics of the Taixing study population were previously reported and are presented in Table 1 [13, 27, 28] . Briefly, liver, esophageal, and stomach cancer cases are 78, 65, and 67 % male, and 69 % of controls are male. Tobacco smoking (ever smoking) was reported by 53, 54, and 53 % of liver, esophageal, and stomach cancer cases, and by 48 % of controls. Approximately 65 % of liver cancer cases were positive for hepatitis B exposure and 9 % were positive for hepatitis C exposure, compared to 25 % (hepatitis B) and 3 % (hepatitis C) of controls. Thirty-five percent (35 %) of stomach cancer cases were exposed to H. pylori as defined by the presence of anti-(CagA-HP) IgG, compared to 28 % of controls. Among 202 esophageal cancer cases, cancer was located in the upper (n = 125, 61.8 %), middle (n = 58, 28.7 %), and lower (n = 19, 9.4 %) third of the esophagus. Cancer was located in the cardia (n = 93, 71 %), body (n = 18, 13.7 %), antrum (n = 17, 13 %), and pylorus (n = 3, 2.3 %) of 131 stomach cancer cases. Liver cancer was distributed between the left (n = 78, 55.3 %) and right (n = 63, 44.7 %) lobes in 141 liver cancer cases.
Family history of any cancer was positively associated with liver (OR adj 2.52; 95 % CI 1.63-3.88) and stomach Table 2 ). The 8q24 SNPs included in this study (rs6983267, rs1447295, rs16901979) are not in linkage disequilibrium (r 2 \ 0.20) with one another. Genotype frequencies for their association with liver, stomach, and esophageal cancers have been reported elsewhere [30] and are presented in Table 3 . In our previously published study, we did not observe a relationship between the A risk allele of rs1447295 and esophageal, stomach, or liver cancers [30] . In this study, after stratification on family history of cancer (Table 4) , we observed a positive association between rs1447295 and liver cancer among those with a family history of cancer (OR adj 2.80; 95 % CI 1.15-6.80), in the dominant model, consistent with a departure from multiplicativity (ROR adj 2.54; 95 % CI 0.94-6.87). The observed association persisted in the hepatitis B negative subgroup analysis (OR adj 3.52; 95 % CI 1.10-11.1) presented in Table 5 and is consistent with the analysis of family history of cancer in first-degree relatives only (Supplemental Table) .
In this study, we observed family history of cancer as a modifier of the association of rs6983267 and liver cancer (P heterogeneity = 0.029). Among those with family history of cancer, the GT heterozygous genotype (OR adj 2.61; 95 % 11-4.16) . A similar pattern of association was also suggested among those with a family history of cancer in first-degree relatives only (Supplemental Table) . The observed heterogeneity is consistent with a departure from multiplicativity (ROR adj 1.81; 95 % CI 0.67-4.85) and persisted in the hepatitis B negative subgroup analysis (P heterogeneity = 0.040) presented in Table 5 . No clear association was observed between 8q24 SNPs and stomach and esophageal cancers in family history-stratified analyses.
The departures from multiplicativity observed with the 8q24 SNPs are consistent with the genetic risk score for the 8q24 SNP-set and family history of cancer (Table 6 ). There is a two-fold greater risk of liver cancer (OR adj 2.00; 95 % CI 1.15-3.47), per additional 8q24 SNP risk genotype, among those with a family history of cancer (P heterogeneity = 0.086).
Discussion
In this study, family history of cancer is associated with cancers of the liver and stomach. We observed that rs1447295 was positively associated with liver cancer among those who reported having a family history of cancer. The relationship between the A risk allele of rs1447295and liver cancer in those with a family history of cancer, but not in those without a family history of cancer, is consistent with previously published studies that reported positive associations for rs1447295 and familial prostate cancer [41] [42] [43] [44] . A functional role for the A risk allele of rs1447295 has yet to be established. There is evidence of linkage disequilibrium between rs1447295 and DG8S737, a microsatellite that is positively associated with prostate cancer, and also the suggestion that both mark a functional causal variant [18, 19, 42, 43, 45, 46] . DG8S737 was not assayed in this study and we could not assess a potential association with liver cancer or potential LD with rs1447295 within this population. In addition to our findings with rs1447295, we also observed heterogeneity in the family history-stratified association of rs6983267 and liver cancer that might potentially indicate inherited susceptibility to the risk associated with the recessive G allele in familial cancer clusters. Our findings in this candidate gene study of rs6983267 and liver cancer are similar to another recent candidate gene study, where the G allele was associated with thyroid cancer in a recessive inheritance model [23] . The Jones et al. [23] study also observed heterogeneity in the association of thyroid cancer and recessive GG homozygotes, in comparison to GT heterozygotes. We did not detect an additive relationship for rs6983267 and liver cancer, among those with a family history of cancer, which might be due to sample size or to a non-additive mechanism. Inherited allelic instability at rs6983267 might also explain our findings of GT heterozygotes with a family history of cancer experiencing the same risk as recessive GG homozygotes without a family history of cancer.
Functional studies have demonstrated that the G risk allele of rs6983267 enhances transcription of the Myc oncogene, which in turn affects Wnt pathway signaling [47] [48] [49] [50] [51] [52] [53] [54] [55] . Beebe-Dimmer et al. [41] have published their observations of preferential germline transmission of the G risk allele of rs6983267 in familial prostate cancer cases. Tuupanen and colleagues have suggested a role for allelic Table 4 Association between 8q24 SNP genotypes and upper gastrointestinal cancers, stratified by family history of cancer imbalance at rs6983267 and amplification of the G risk allele by comparing germline rs6983267 genotypes of colorectal cancer patients and their relatives, with somatic rs6983267 genotypes of patients' tumors [36, 51] . In light of these studies, our findings are consistent with rs6983267 operating in families as what Tuupanen et al. [36] describe as a ''germline predisposition SNP to somatic tumor evolution''. The heterogeneity in the 8q24 genetic risk score by family history of cancer is consistent with previously reported observations in familial colorectal cancer cases [25] and could potentially be explained by allelic transmission disequilibrium in families or by co-inheritance of 8q24 loci with an unknown disease marker. Our findings demonstrate the importance of including family history of cancer in studies of low penetrance genetic variation to generate hypotheses that can be tested in subsequent family-based studies.
This study had some limitations. Although genotypic and infection-related data are not affected by recall bias, recall bias may be present in self-reported family history of cancer and may be differential. However, we expect this bias to be minimal given that previously published studies have reported allelic transmission disequilibrium and have observed a difference in the number of risk alleles transmitted to familial cancer cases [34, 41, 43, 56] . A strength of this study is the ability to stratify on family history of any cancer and family history of index cancer in a racially homogenous population. Studies of familial clustering of liver cancer in Asian populations have partially attributed observed positive associations to hepatitis B infection. We cannot rule out shared environmental factors; however, we were able to adjust our ORs for those infectious risk factors associated with liver and stomach cancers, and shared within families. Our adjusted estimates are consistent with published studies of hepatitis B-negative European and American populations, which reported ORs ranging from 1.4 to 2.4 for the association of family history of cancer and liver cancer [2, 5] . Furthermore, the magnitude and direction of associations that we observed in the overall population persisted in our hepatitis B-negative subgroup analysis.
In conclusion, this study finds that the association of rs6983267 and rs1447295 with liver cancer varies by family history of cancer. The hypothesis generated in this study, namely that there is an inherited predisposition towards allelic imbalance or loss of heterozygosity at rs6983267, warrants further investigation in larger population-based and family-based studies. Further investigation is also needed into the genetic epidemiology of rs6983267 and rs1447295, in order to understand the potential for linkage with causal markers or possible transmission disequilibrium of risk alleles. 
